Доход Novo Nordisk является kr52.825B
Чистая прибыль, подлежащая распределению среди обычных акционеров, равна чистой прибыли за вычетом выплаченных привилегированных дивидендов.
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.